Alliancebernstein L.P. Gritstone Bio, Inc. Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$1.66 - $3.03 $29,880 - $54,540	18,000 New	18,000 $35,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $74,694 - $183,148	-42,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $403 - $1,219	100 Added 0.24%	42,200 $174,000
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $79,716 - $124,761	9,100 Added 27.58%	42,100 $541,000
Q2 2021 Jul 30, 2021	BUY	$8.13 - $10.2 $69,918 - $87,720	8,600 Added 35.25%	33,000 $301,000
Q1 2021 May 06, 2021	SELL	$4.07 - $27.11 $66,748 - $444,604	-16,400 Reduced 40.2%	24,400 $230,000
Q3 2020 Nov 12, 2020	SELL	$2.63 - $8.09 $10,520 - $32,360	-4,000 Reduced 8.93%	40,800 $108,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $8.17 $104,696 - $150,328	18,400 Added 69.7%	44,800 $297,000
Q1 2020 May 14, 2020	BUY	$5.47 - $11.3 $42,666 - $88,140	7,800 Added 41.94%	26,400 $154,000
Q3 2019 Nov 14, 2019	BUY	$8.45 - $12.28 $46,474 - $67,540	5,500 Added 41.98%	18,600 $161,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $120,519 - $205,670	13,100 New	13,100 $146,000
Q4 2018 Feb 13, 2019	SELL	$11.61 - $31.1 $232,200 - $622,000	-20,000 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$14.24 - $14.24 $284,800 - $284,800	20,000 New	20,000 $285,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.